MedTrace Logo

Post Operative Nausea and Vomiting (PONV) Rescue Outcomes After Amisulpride Treatment

NCT04954365 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-04-07

No results posted yet for this study

Summary

PROMPT (PONV Rescue Outcomes after AMisulPride Treatment) is an observational Phase IV study designed to evaluate real-world evidence in relation to the care continuum of Post Operative Nausea and Vomiting (PONV), as well as the effectiveness and safety of common pharmacologic rescue treatment regimens compared to IV amisulpride. There will be no predefined hypothesis regarding the magnitude of efficacy or safety of various treatment regimens from the cohorts observed. We are not proposing to directly recruit patients into this study.

Conditions

  • Nausea and Vomiting, Postoperative

Interventions

DRUG

Rescue Post-Operative Nausea and Vomiting (PONV) treatment according to the standard of care (SOC)

Rescue Post-Operative Nausea and Vomiting (PONV) treatment

DRUG

Amisulpride

Rescue Post-Operative Nausea and Vomiting (PONV) treatment with Amisulpride

Sponsors & Collaborators

  • ArborMetrix

    collaborator UNKNOWN

  • Acacia Pharma Ltd

    lead INDUSTRY

Principal Investigators

  • Lynn Bichajian, MD · Acacia Pharma

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2024-12-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04954365 on ClinicalTrials.gov